press-release Market Intelligence /marketintelligence/en/media-center/press-release/new-pharmaceutical-supply-chain-intelligence-from-panjiva-tracks-drug-shipments-and-inventory-activities content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

New Pharmaceutical Supply Chain Intelligence from Panjiva Tracks Drug Shipments and Inventory Activities

Latest alternative data set from S&P Global unlocks global supply chain connections in generic drug manufacturers with robust linking capabilities

New York, Jan. 14 2019 — S&P Global Market Intelligence announced today the introduction of new alternative data set through its data feed management system, Xpressfeed™. This pharmaceutical package is a curated, sector-specific data feed which maps Panjiva supply chain data to the Food and Drug Administration’s (FDA) Orange Book. This solution allows users to monitor and track pharmaceutical shipments to generic drug manufacturers leading up to official FDA announcements.

“This Panjiva Pharmaceutical data package is the foundation for benchmarking industry activity and providing insight into market changes, market entry, patent challenges, and inventory activities of generic drug manufacturers. The latest addition demonstrates our continuous commitment to bringing transparency to global supply chains,” said Josh Green, co-founder of Panjiva.

Warren Breakstone, Managing Director and Chief Product Officer for Data Management Solutions at S&P Global Market Intelligence added, “This new source of alternative data offered via Xpressfeed provides new insights to investors and decision makers. Changes in shipment behaviour is a potential indication of FDA approval for generic distribution of drugs coming off patent and an important investment signal.”

Client use cases for this data are highlighted in the Panjiva Daily, a curated newsletter available to all clients that offers insights into supply chain trends ranging from policy impact, logistics, and industrial aspects.

Panjiva’s supply chain data was integrated to Xpressfeed in September of 2018. The latest pharmaceutical data set further complements S&P Global’s supply chain capabilities, offering clients a collection of essential intelligence to understand global company relationships.

To learn more about Xpressfeed and the new product rollouts, please click here.

About S&P Global Market Intelligence

At S&P Global Market Intelligence, we know that not all information is important—some of it is vital. We integrate financial and industry data, research and news into tools that help track performance, generate alpha, identify investment ideas, understand competitive and industry dynamics, perform valuations and assess credit risk. Investment professionals, government agencies, corporations and universities globally can gain the intelligence essential to making business and financial decisions with conviction.

S&P Global Market Intelligence is a division of S&P Global (NYSE: SPGI). For more information, visit www.spglobal.com.

Learn more about Market Intelligence
Request Demo

Media Contact

Vivian Liu, S&P Global Market Intelligence
P.   +852 2841 1007
E. Vivian.Liu@spglobal.com

Submitting your email above means you agree to the Terms and have read and understood the Privacy Policy